Smoking Cessation by Phone Counselling in a Lung Cancer Screening Program: A Retrospective Comparative Cohort Study.


Journal

Canadian respiratory journal
ISSN: 1916-7245
Titre abrégé: Can Respir J
Pays: Egypt
ID NLM: 9433332

Informations de publication

Date de publication:
2022
Historique:
received: 16 09 2021
revised: 10 03 2022
accepted: 21 03 2022
entrez: 2 5 2022
pubmed: 3 5 2022
medline: 4 5 2022
Statut: epublish

Résumé

Smoking cessation integration within lung cancer screening programs is challenging. Currently, phone counselling is available across Canada for individuals referred by healthcare workers and by self-referral. We compared quit rates after phone counselling interventions between participants who self-refer, those referred by healthcare workers, and those referred by a lung cancer screening program. This is a retrospective cohort study of participants referred to provincial smoking cessation quit line in contemporaneous cohorts: self-referred participants, healthcare worker referred, and those referred by a lung cancer screening program if they were still actively smoking at the time of first contact. Baseline, covariates (sociodemographic information, smoking history, and history of mental health disorder) and quit intentions (stage of change, readiness for change, previous use of quit programs, and previous quit attempts) were compared among the three cohorts. Our primary outcome was defined as self-reported 30-day abstinence rates at 6 months. Multivariable logistic regression was used to identify whether group assignment was associated with higher quit rates. Participants referred by a lung cancer screening program had low quit rates (12%, 95% CI: 5-19) at six months despite the use of phone counselling. Compared to patients who were self-referred to the smoking cessation phone helpline, individuals referred by a lung cancer screening program were much less likely to quit (adjusted OR 0.37; 95% CI: 0.17-0.8), whereas those referred by healthcare workers were twice as likely to quit (adjusted OR 2.16 (1.3-3.58)) even after adjustment for differences in smoking intensity and quit intentions. Phone counselling alone has very limited benefit in a lung cancer screening program. Participants differ significantly from those who are otherwise referred by healthcare workers. This study underlines the importance of a dedicated and personalized tobacco treatment program within every lung cancer screening program. The program should incorporate best practices and encourage treatment regardless of readiness to quit.

Identifiants

pubmed: 35495872
doi: 10.1155/2022/5446751
pmc: PMC9050320
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

5446751

Informations de copyright

Copyright © 2022 Ankita Ghatak et al.

Déclaration de conflit d'intérêts

NE works as a consultant for the Programme Quebecois de Cancerologie lung cancer screening demonstration project. All other authors declare that they have no conflicts of interest.

Références

Tumori. 2015 May-Jun;101(3):306-11
pubmed: 25838249
Lung Cancer. 2019 Sep;135:205-216
pubmed: 31446996
Cancer. 2016 Apr 15;122(8):1150-9
pubmed: 26916412
J Consult Clin Psychol. 1983 Jun;51(3):390-5
pubmed: 6863699
N Engl J Med. 2020 Feb 6;382(6):503-513
pubmed: 31995683
Am J Respir Crit Care Med. 2016 Mar 1;193(5):534-41
pubmed: 26502000
Lung Cancer. 2012 May;76(2):204-10
pubmed: 22054915
Cochrane Database Syst Rev. 2010 Nov 10;(11):CD004492
pubmed: 21069681
Lung. 2015 Feb;193(1):147-9
pubmed: 25323328
Addict Behav. 2020 Apr;103:106222
pubmed: 31838445
N Engl J Med. 2011 Aug 4;365(5):395-409
pubmed: 21714641
Transl Lung Cancer Res. 2021 Feb;10(2):1099-1109
pubmed: 33718048
Lancet Oncol. 2017 Nov;18(11):1523-1531
pubmed: 29055736
Lung Cancer. 2004 Apr;44(1):13-21
pubmed: 15013579
Nicotine Tob Res. 2020 Aug 24;22(9):1484-1491
pubmed: 31504798
J Thorac Oncol. 2019 Sep;14(9):1528-1537
pubmed: 31077790
Transl Lung Cancer Res. 2019 May;8(Suppl 1):S11-S20
pubmed: 31211102
Ann Transl Med. 2016 Apr;4(8):157
pubmed: 27195275
JAMIA Open. 2018 May 23;1(1):26-31
pubmed: 31984317
Br J Addict. 1989 Jul;84(7):791-9
pubmed: 2758152
Ann Oncol. 2019 Jul 1;30(7):1162-1169
pubmed: 30937431

Auteurs

Ankita Ghatak (A)

Division of Experimental Medicine, Department of Medicine, McGill University, Montreal, Quebec, Canada.

Sean Gilman (S)

Department of Medicine, Division of Respiratory Medicine, McGill University Health Centre, Montreal, Quebec, Canada.

Siobhan Carney (S)

Department of Medicine, Division of Respiratory Medicine, McGill University Health Centre, Montreal, Quebec, Canada.

Anne V Gonzalez (AV)

Division of Experimental Medicine, Department of Medicine, McGill University, Montreal, Quebec, Canada.
Department of Medicine, Division of Respiratory Medicine, McGill University Health Centre, Montreal, Quebec, Canada.

Andrea Benedetti (A)

Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
Center for Outcomes Research and Evaluation, McGill University Health Centre, Montreal, Quebec, Canada.
Department of Epidemiology, Biostatistics & Occupational Health, McGill University, Montreal, Quebec, Canada.

Nicole Ezer (N)

Division of Experimental Medicine, Department of Medicine, McGill University, Montreal, Quebec, Canada.
Department of Medicine, Division of Respiratory Medicine, McGill University Health Centre, Montreal, Quebec, Canada.
Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
Center for Outcomes Research and Evaluation, McGill University Health Centre, Montreal, Quebec, Canada.
Department of Epidemiology, Biostatistics & Occupational Health, McGill University, Montreal, Quebec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH